openPR Logo
Press release

Implantable Insulin Pump Market Poised for 9.5 % Growth, Set to Hit $1.71 Billion by 2029

03-26-2025 06:36 AM CET | Health & Medicine

Press release from: The Business Research Company

Implantable Insulin Pump

Implantable Insulin Pump

Which drivers are expected to have the greatest impact on the over the implantable insulin pump market's growth?
The surge in diabetes-related occurrences is anticipated to fuel the momentum of the implantable insulin pump industry. Diabetes is a chronic condition characterized by the body's struggle to regulate blood sugar levels due to insufficient insulin production or ineffective cellular insulin usage. Increasing diabetes cases can be attributed to factors such as escalated obesity rates, a lack of physical exercise, poor diets, and an aging populace. An implantable insulin pump provides precise, continuous insulin supply, stabilizing blood glucose levels, reducing the need for injections, and enhancing overall diabetes control and quality of life. For example, in May 2024, a report released by Diabetes UK, a charity dedicated to people with diabetes in the UK, stated that over 5.6 million people in the UK are living with diabetes. This denotes an addition of 167,822 cases from the 2022-23 figures, representing a growth compared to the prior year. Consequently, the growth of the implantable insulin pump market is catalyzed by the escalating diabetes occurrences.

Get Your Implantable Insulin Pump Market Report Here:
https://www.thebusinessresearchcompany.com/report/implantable-insulin-pump-global-market-report

What is the future CAGR of the implantable insulin pump market, and how will it impact industry expansion?
In recent years, the market size of implantable insulin pumps has seen substantial growth. It is projected to rise from $3.54 billion in 2024 to $3.88 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%. Factors like the growing number of diabetes cases, enhancements in insulin delivery systems, increased awareness about diabetes management, a surge in patient requirement for convenience, and favorable government regulations for diabetes treatment have all contributed to this growth during the historic period.

The market size of insulin pumps that can be implanted is poised for robust expansion in the upcoming years. A growth to $5.57 billion is anticipated by 2029, at a compound annual growth rate (CAGR) of 9.5%. This expected growth during the forecast period is linked to several factors. These include a growing number of diabetes patients, the surge in the adoption of tailored medicine, an increased emphasis on efficient diabetes management, a rising demand for non-invasive monitoring alternatives, and booming healthcare infrastructure and accessibility. Notable trends during this period will likely include the combination of AI and machine learning for improved insulin management, advancements in device miniaturization, seamless integration with mobile applications and cloud-based platforms, the creation of pumps with advanced safety features, and continuous research and innovations.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20565&type=smp

What are the most significant trends transforming the implantable insulin pump market today?
Leading firms in the implantable insulin pump market are concentrating their efforts on creating high-tech products such as closed-loop insulin pump systems in order to enhance patient outcomes by automating insulin dispensation based on real-time glucose measurements. The closed-loop insulin pump system, also known as the artificial pancreas, regulates insulin infusion automatically using up-to-the-minute glucose data. This device merges an insulin pump, a continuous glucose tracker, and an algorithm to maintain blood sugar levels without manual input. For instance, in March 2022, Medtronic India Pvt. Ltd., a healthcare technology company based in India, introduced the MiniMed 780G system in India. This forward-looking closed-loop insulin pump system dispenses basal insulin and correction boluses every five minutes, aiding in balancing blood sugar levels. It allows patients to set glucose targets as low as 100 mg/dL, exceeding other modern hybrid systems' capabilities in glucose regulation. The system's Bluetooth function allows both users and caregivers to track real-time glucose data and tendencies via compatible iPhone operating system (iOS) and Android applications. This system simplifies diabetes management for healthcare providers, requiring only a few tweaks to achieve maximum effectiveness.

Which key market segments comprise the implantable insulin pump market and drive its revenue growth?
The implantable insulin pump market covered in this report is segmented -

1) By Type: Closed-Loop Insulin Pump, Open-Loop Insulin Pump
2) By Application: Type 1 Diabetes, Type 2 Diabetes
3) By End-User: Hospitals, Home-Care

Subsegments:
1) By Closed-Loop Insulin Pump: Fully Automated Closed-Loop Insulin Pump, Hybrid Closed-Loop Insulin Pump, Closed-Loop Insulin Pump with Continuous Glucose Monitoring (CGM), Closed-Loop Insulin Pump with Adaptive Insulin Delivery
2) By Open-Loop Insulin Pump: Manual Open-Loop Insulin Pump, Basal-Bolus Open-Loop Insulin Pump, Smart Open-Loop Insulin Pump, Patch-Style Open-Loop Insulin Pump

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20565

What regions are at the forefront of implantable insulin pump market expansion?
North America was the largest region in the implantable insulin pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable insulin pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the implantable insulin pump market?
Major companies operating in the implantable insulin pump market are Sanofi S.A., Abbott Laboratories, Medtronic plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Air Liquide Healthcare Ltd., Diabeloop SA, Glooko Inc., ViCentra B.V., Bigfoot Biomedical Inc., Beta Bionics Inc., Senseonics Holdings Inc., INREDA DIABETIC B.V., TIDEPOOL Inc., Medtrum Technologies Inc., Sernova Corp., PhysioLogic Devices Inc., EOFLOW CO. LTD., CamDiab Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20565&type=smp

What Is Covered In The Implantable Insulin Pump Global Market Report?

•Market Size Forecast: Examine the implantable insulin pump market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the implantable insulin pump market for a structured understanding.
•Key Players Overview: Analyze major players in the implantable insulin pump market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the implantable insulin pump market.
•Segment Contributions: Evaluate how different segments drive overall growth in the implantable insulin pump market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the implantable insulin pump market.
•Industry Challenges: Identify potential risks and obstacles affecting the implantable insulin pump market.
•Competitive Landscape: Review strategic developments in the implantable insulin pump market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Implantable Insulin Pump Market Poised for 9.5 % Growth, Set to Hit $1.71 Billion by 2029 here

News-ID: 3938095 • Views:

More Releases from The Business Research Company

Key Drivers Reshaping the Purvalanol A (CDK Inhibitor) Market: Increasing Prevalence Of Cancer Driving The Growth Of The Market Due To Rising Aging Populations And Higher Cancer Risk Industry Transformation
Key Drivers Reshaping the Purvalanol A (CDK Inhibitor) Market: Increasing Preval …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Purvalanol A (CDK Inhibitor) Market Size Growth Forecast: What to Expect by 2025? The market size for purvalanol A (CDK inhibitor) has witnessed a substantial expansion in the past few years. It is projected to escalate from $0.58 billion in 2024 to $0.64 billion in 2025, with a compound
Growing Emphasis On Personalized Medicine Driving The Market Due To Advances In Genomics And Tailored Treatment Approaches: The Driving Engine Behind Polygenic Risk Score Services Market Evolution in 2025
Growing Emphasis On Personalized Medicine Driving The Market Due To Advances In …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Polygenic Risk Score Services Market Size Growth Forecast: What to Expect by 2025? The market size for polygenic risk score services has seen considerable growth in recent years. Anticipated to increase from $1.24 billion in 2024 to $1.45 billion in 2025, it projects a compound annual growth rate (CAGR)
Future of the Global Pharmaceutical Unit-Dose Packaging Market: Trends, Innovations, and Key Forecasts Through 2034
Future of the Global Pharmaceutical Unit-Dose Packaging Market: Trends, Innovati …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pharmaceutical Unit-Dose Packaging Market Size Growth Forecast: What to Expect by 2025? The market size of the pharmaceutical unit-dose packaging industry has experienced quick expansion in the recent past. The market, valued at $48.78 billion in 2024, is projected to rise to $54.50 billion in 2025, reflecting a compound
Personal Care Product Testing Market Poised to Hit $10.37 Billion by 2029 with Accelerating Growth Trends
Personal Care Product Testing Market Poised to Hit $10.37 Billion by 2029 with A …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Personal Care Product Testing Market Size Growth Forecast: What to Expect by 2025? In the past few years, the market size for personal care product testing has seen robust growth. It's projected to increase from $7.28 billion in 2024 to $7.84 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Insulin

Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Insulin Pumps Market Share, Trends and Growth Analysis By Type (Traditional Insu …
Insulin Pumps Market is expected to register a CAGR of 15.5% and acquire the market value of USD 11.5 Billion by 2028 during forecast period 2023-2032. Insulin pumps are discreet, electronic medical devices that can be tucked beneath clothing or fastened to a belt. In order to regulate the rise in blood glucose levels, the pump is used to deliver controlled quantities of insulin within the body at regular intervals
Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin